IPILIMUMAB for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 530 adverse event reports in the FDA FAERS database where IPILIMUMAB was used for Lung neoplasm malignant.
Most Reported Side Effects for IPILIMUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 3,710 | 10.2% | 3,709 | 285 |
| Malignant neoplasm progression | 3,296 | 9.0% | 1,570 | 1,538 |
| Diarrhoea | 2,557 | 7.0% | 305 | 1,643 |
| Off label use | 2,097 | 5.7% | 528 | 731 |
| Colitis | 1,988 | 5.4% | 293 | 1,229 |
| Pyrexia | 1,796 | 4.9% | 237 | 1,336 |
| Rash | 1,556 | 4.3% | 162 | 694 |
| Fatigue | 1,447 | 4.0% | 176 | 776 |
| Intentional product use issue | 1,329 | 3.6% | 563 | 347 |
| Nausea | 1,169 | 3.2% | 139 | 773 |
| Decreased appetite | 990 | 2.7% | 136 | 665 |
| Immune-mediated enterocolitis | 988 | 2.7% | 73 | 504 |
| Hypophysitis | 981 | 2.7% | 61 | 515 |
| Dyspnoea | 906 | 2.5% | 165 | 651 |
| Pneumonitis | 891 | 2.4% | 220 | 560 |
Other Indications for IPILIMUMAB
Malignant melanoma (8,903)
Product used for unknown indication (4,980)
Metastatic malignant melanoma (4,430)
Non-small cell lung cancer (2,987)
Renal cell carcinoma (2,585)
Metastatic renal cell carcinoma (1,826)
Non-small cell lung cancer recurrent (1,089)
Small cell lung cancer (474)
Pleural mesothelioma malignant (473)
Renal cancer (440)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)